A new probiotic bacteria called Lactococcus cremoris FBMS_5810 shows promise for supporting gut health, according to Gram Research analysis of a 2026 study. In mice, this probiotic changed the balance of gut bacteria and increased production of intestinal barrier proteins, suggesting it may help maintain digestive health and reduce inflammation-related problems. However, human studies are needed before this strain becomes available as a consumer product.
Scientists have discovered and tested a new probiotic bacteria called Lactococcus cremoris FBMS_5810 that may help support a healthy gut. According to Gram Research analysis, researchers studied this bacteria’s genetic makeup and tested it in mice to see if it was safe and effective. The results showed that this probiotic changed the balance of bacteria in the gut and affected how the intestines work, suggesting it could potentially help prevent digestive and inflammation-related problems. While these early results are promising, more research in humans is needed before this probiotic becomes available as a health product.
Key Statistics
A 2026 research article in Frontiers in Microbiology found that Lactococcus cremoris FBMS_5810 increased beneficial bacteria families including Muribaculaceae, Erysipelotrichaceae, and Streptococcaceae while decreasing potentially harmful bacteria in mice.
The probiotic strain Lactococcus cremoris FBMS_5810 elevated intestinal barrier protein (Zo1) expression in the cecum and increased immune markers (Tnf and Il1b) in the ileum of mice, suggesting multiple mechanisms for supporting gut health.
Genetic analysis of Lactococcus cremoris FBMS_5810 identified strain-specific genes linked to adhesion, colonization, and pathogen exclusion that aligned with previously observed probiotic properties in laboratory testing.
The Quick Take
- What they studied: Whether a newly discovered probiotic bacteria called Lactococcus cremoris FBMS_5810 is safe and could help maintain a healthy gut
- Who participated: Healthy laboratory mice received the probiotic strain while researchers monitored changes in their gut bacteria and intestinal health markers
- Key finding: The probiotic changed which bacteria lived in the mice’s guts and affected how their intestines worked, suggesting it may support digestive health
- What it means for you: This research is early-stage laboratory work. While results are encouraging, human studies are needed before this probiotic could become a consumer product. Don’t expect this specific strain to be available soon, but it represents progress in finding new probiotics
The Research Details
Researchers took a two-step approach to evaluate this probiotic candidate. First, they analyzed the bacteria’s genetic code (DNA) to understand what makes it unique and what abilities it has. They looked for specific genes that help the bacteria stick to intestinal walls, survive in the gut, and fight off harmful bacteria. Second, they tested the probiotic in healthy mice by giving it to them and measuring what happened to their gut bacteria and intestinal function over time. This combination of genetic analysis and live animal testing helps scientists understand both how the bacteria works and whether it’s safe.
This research approach is important because it combines two types of evidence. Genetic analysis shows what the bacteria is theoretically capable of doing, while animal testing shows whether it actually works that way in a living body. This two-step process helps scientists identify promising probiotic candidates before investing in expensive human trials, and it helps ensure safety before testing in people.
This is a well-designed preclinical study published in a respected scientific journal. The researchers used established methods for genetic analysis and proper controls in their animal studies. However, this is laboratory research in mice, not humans. The study doesn’t specify how many mice were used, which is important information. Results in mice don’t always translate to humans, so human studies would be needed to confirm these findings apply to people
What the Results Show
When mice received this probiotic, their gut bacteria composition changed noticeably. Certain beneficial bacteria families increased in abundance, including Muribaculaceae, Erysipelotrichaceae, and Streptococcaceae. At the same time, other bacteria families decreased, including Ruminococcaceae, Bacteroidaceae, Porphyromonadaceae, and Dehalobacteriaceae. These changes suggest the probiotic influences which bacteria thrive in the gut environment. Additionally, the probiotic affected how the intestines worked at a molecular level. In one part of the small intestine (the ileum), markers of immune activity increased. In another part (the cecum), a protein that helps maintain the intestinal barrier increased. These changes suggest the probiotic may help the intestines maintain proper function and support immune health.
The genetic analysis revealed that this probiotic strain has unique genes related to how it attaches to intestinal cells, colonizes the gut, and excludes harmful bacteria. These genetic features align with what scientists had already observed when testing the bacteria in laboratory dishes, suggesting the genetic predictions matched real-world behavior. The combination of genetic capabilities and demonstrated effects in mice suggests this strain has multiple ways of supporting gut health
This research builds on growing interest in using specific probiotic strains to support digestive health. Previous studies have shown that different probiotic bacteria can change gut composition and affect intestinal function, but each strain works differently. This study adds to that knowledge by identifying a new candidate strain with specific genetic features and demonstrating its effects in living animals. The approach of combining genetic analysis with animal testing is becoming standard practice in probiotic research
This study has several important limitations. It was conducted only in mice, which have different digestive systems than humans. The study doesn’t specify the sample size, making it difficult to assess statistical power. The research was done in healthy mice, so it’s unclear whether this probiotic would work the same way in people with digestive problems or disease. Long-term effects weren’t measured. Finally, this is preclinical research—human studies would be needed to determine if these benefits apply to people and whether the probiotic is safe for human consumption
The Bottom Line
This research is too early-stage to make recommendations for consumers. The findings suggest this probiotic candidate warrants further investigation, but human clinical trials are necessary before it could be recommended. If and when human studies are conducted, they should measure effects on digestive health, immune function, and safety in different populations. Confidence level: Low for human application at this stage; High for the scientific merit of pursuing further research
Microbiologists and probiotic researchers should pay attention to this work as it demonstrates a systematic approach to identifying and validating new probiotic candidates. Healthcare providers interested in probiotics should note this as an emerging candidate for future consideration. The general public should understand this represents basic research progress, not a product ready for use. People with digestive concerns should not expect this specific strain to be available soon
This is preclinical research, so realistic timelines are long. If human studies begin soon, it would typically take 3-5 years to complete initial safety and efficacy trials. Regulatory approval and commercialization could take several additional years. A realistic expectation is that this specific strain might become available as a commercial probiotic product within 5-10 years, if further research continues to show promise
Frequently Asked Questions
Is Lactococcus cremoris FBMS_5810 available as a probiotic supplement now?
No, this probiotic is still in early research stages. The 2026 study tested it only in mice. Human clinical trials would be needed before it could be approved and sold as a supplement, which typically takes several years.
How does this probiotic strain change the gut microbiome?
According to the research, Lactococcus cremoris FBMS_5810 increases beneficial bacteria families like Muribaculaceae while decreasing potentially harmful bacteria like Ruminococcaceae. It also boosts intestinal barrier proteins that help maintain gut health.
Can I use this probiotic if I have digestive problems?
Not yet. The study only tested this strain in healthy mice. Researchers don’t yet know if it would help people with digestive disorders or if it’s safe for those with specific health conditions. Wait for human studies before considering it.
What makes this probiotic different from other probiotic strains?
This strain has unique genes for sticking to intestinal cells and fighting harmful bacteria. The research shows it affects gut bacteria composition and intestinal function in multiple ways, suggesting it may work differently than other probiotics.
When will this probiotic be available for consumers?
If research continues successfully, this strain might become available as a commercial product within 5-10 years. First, scientists need to complete human safety and effectiveness studies, then seek regulatory approval before it can be sold.
Want to Apply This Research?
- Once this probiotic becomes available, users could track digestive symptoms (bloating, regularity, discomfort) on a 1-10 scale daily and note any changes after starting supplementation, comparing baseline symptoms to post-supplementation weeks 2, 4, and 8
- When this probiotic becomes available, users could set a daily reminder to take it consistently at the same time each day, paired with a high-fiber meal to support the probiotic’s effectiveness
- Long-term tracking could include monthly assessments of digestive comfort, energy levels, and immune health markers (like frequency of colds), comparing 3-month periods before and after supplementation to identify patterns
This research describes early-stage laboratory findings in mice and does not represent approved medical treatment or consumer products. Lactococcus cremoris FBMS_5810 is not currently available for human use. These results do not constitute medical advice. Before starting any probiotic supplement, consult with a healthcare provider, especially if you have digestive disorders, compromised immunity, or take medications. This study’s findings in mice may not apply to humans. Always seek professional medical guidance for digestive health concerns.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.